Systemic Absorption and Side Effects of Locally Injected Glucocorticoids

Abstract

Local glucocorticoid injections are often used to treat joint, soft tissue, or spinal pain, but the systemic side effects associated with these injections are poorly understood and not well recognized. There are significant known risks to systemic administration of glucocorticoids. However, there are no guidelines that address issues of systemic absorption, overall systemic risks, or other side effects of locally injected glucocorticoids. For this review, a literature search was performed, and the available evidence on systemic absorption and clinical side effects of intra‐articular and epidural glucocorticoids was synthesized. The goal was to improve clinical understanding of risks associated with these injections. Existing data suggest there is significant individual variability in the amount of systemic absorption and clinical effects of locally injected glucocorticoids. However, it is clear that both intra‐articular and epidural injections can have systemic effects for weeks and that complications may be associated with their use, including Cushing syndrome, loss of bone density, infection, and hyperglycemia. The concurrent use of oral steroids, the number of injections, and the type and dose of glucocorticoids used all are important considerations in estimating risks. The total dose calculation of cumulative glucocorticoid exposure should include all local injections. Caution should be exercised when local glucocorticoid injections are used in higher risk patients, such as postmenopausal women, people with diabetes, and those considering surgery in the near term. Better provider awareness of possible systemic risks should improve decision making and informed consent with patients when considering intra‐articular and epidural steroid injections for painful conditions. Level of Evidence IV

Corticosteroid Injections and COVID-19 Infection Risk

“…Additionally, patient variables, comorbidities, and certain medications can significantly affect the magnitude and duration of HPA axis suppression. Systemic effects of epidurally administered corticosteroids are inadequately studied and underappreciated [ 12 ]. The known protracted dysfunction of the endocrine system from a single epidural steroid injection suggests that parallel systemic effects on the immune response are likely, though this has not been directly studied.…”

Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic

“…For example, the median elimination half-life of triamcinolone injected into the epidural space is almost 9 days ( 26 ), causing HPA axis suppression that lasts several weeks. Quantifying systemic dose and risk is challenging, starting with the notion of identifying a threshold of safe number of injections or total milligrams of glucocorticoid injected per year ( 27 ). Prolonged adrenal suppression results in adrenal atrophy, and abrupt withdrawal of glucocorticoids may rapidly lead to adrenal crisis.…”

Resveratrol Can Attenuate Astrocyte Activation to Treat Spinal Cord Injury by Inhibiting Inflammatory Responses

“…Presently, some glucocorticoids are commonly used in the clinic to prevent this mechanism of neuroinflammation caused by secondary SCI. However, long-term clinical use of these agents diminishes their effectiveness, coupled with significant side effects [ 19 ]. Therefore, modern interventional agents having minimal to no side effects concomitant with favorable therapeutic effects are needed.…”